1-6 of 6
Authors: Mauricio Tohen
Journal Article
The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder
International Journal of Neuropsychopharmacology, Volume 23, Issue 4, April 2020, Pages 230–256, https://doi.org/10.1093/ijnp/pyz064
Published: 05 December 2019
Journal Article
Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design
International Journal of Neuropsychopharmacology, Volume 20, Issue 2, 1 February 2017, Pages 95–97, https://doi.org/10.1093/ijnp/pyx002
Published: 28 February 2017
Journal Article
Credibility of industry-funded clinical trials
International Journal of Neuropsychopharmacology, Volume 16, Issue 8, September 2013, Pages 1879–1884, https://doi.org/10.1017/S1461145713000461
Published: 01 September 2013
Journal Article
Factors modifying drug and placebo responses in randomized trials for bipolar mania
International Journal of Neuropsychopharmacology, Volume 14, Issue 7, August 2011, Pages 863–875, https://doi.org/10.1017/S1461145710001641
Published: 01 August 2011
Journal Article
Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis
International Journal of Neuropsychopharmacology, Volume 13, Issue 6, July 2010, Pages 813–832, https://doi.org/10.1017/S1461145709991246
Published: 01 July 2010
Journal Article
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression
International Journal of Neuropsychopharmacology, Volume 12, Issue 6, July 2009, Pages 773–782, https://doi.org/10.1017/S1461145708009735
Published: 01 July 2009
